Drug Co. Atara Hit With Investor Suit Over FDA Denial
By Sydney Price · March 24, 2026, 8:27 PM EDT
Drug company Atara Biotherapeutics Inc. has been hit with a proposed class action accusing it of harming investors by not disclosing certain manufacturing problems and research study deficiencies that made it...
To view the full article, register now.